Go to Almac at the 23rd Annual DIA EuroMeeting and Partnerships in Clinical Trials and participate in a special poster presentation by Hannah O’Gorman on Identifying Patients’ Known reasons for noncompliance in ePRO Research to boost Data Collection Methods. .. Almac to launch new services for clinical trial individual management Today that its Clinical Technologies business unit Almac announced, a global head in clinical trial administration, will start a suite of new providers designed to improve patient retention and compliance in clinical trials.Daclatasvir is an important addition to our armamentarium against this disease and will help us to treat patients. Related StoriesNew RNA test of blood platelets can be used to detect area of cancerNew antenna-like device makes breast cancer medical procedures easier for surgeonsNew results reveal association between colorectal tumor and melanoma drug treatmentHepatitis C is certainly a preventable and treatable blood-borne viral disease which, if left untreated, can lead to potentially fatal cirrhosis or cancer of the liver. Latest estimates indicate that 12 approximately,000 folks have chronic HCV in Wales. Having access to new tolerable options that can help to treat these patients is really essential and we welcome this progressive suggestion by the AWMSG.